These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 17201815)
41. High efficacy of panobinostat towards human gastrointestinal stromal tumors in a xenograft mouse model. Floris G; Debiec-Rychter M; Sciot R; Stefan C; Fieuws S; Machiels K; Atadja P; Wozniak A; Faa G; Schöffski P Clin Cancer Res; 2009 Jun; 15(12):4066-76. PubMed ID: 19509176 [TBL] [Abstract][Full Text] [Related]
42. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320 [TBL] [Abstract][Full Text] [Related]
43. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate. Boruban C; Sencan O; Akmansu M; Atik ET; Ozbek S Anticancer Drugs; 2007 Sep; 18(8):969-72. PubMed ID: 17667604 [TBL] [Abstract][Full Text] [Related]
44. Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors. Demetri GD; Wang Y; Wehrle E; Racine A; Nikolova Z; Blanke CD; Joensuu H; von Mehren M J Clin Oncol; 2009 Jul; 27(19):3141-7. PubMed ID: 19451435 [TBL] [Abstract][Full Text] [Related]
45. [Gastrointestinal stromal tumors: open problems]. Peparini N; Maturo A G Chir; 2002 Oct; 23(10):357-9. PubMed ID: 12611255 [No Abstract] [Full Text] [Related]
47. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors? Yoon SS; Tanabe KK Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951 [No Abstract] [Full Text] [Related]
48. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
49. Diagnosing gastrointestinal stromal tumors before the year 2000. Zhuge Y; Cheung MC; Yang R; Koniaris LG Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):1013-4; author reply 1014-5. PubMed ID: 19273490 [No Abstract] [Full Text] [Related]
50. Secondary C-kit mutation is a cause of acquired resistance to imatinib in gastrointestinal stromal tumor. Zheng S; Pan YL; Tao DY; Wang JL; Huang KE Scand J Gastroenterol; 2009; 44(6):760-3. PubMed ID: 19096980 [TBL] [Abstract][Full Text] [Related]
51. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases]. Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842 [TBL] [Abstract][Full Text] [Related]
52. Choroidal metastasis from gastrointestinal stromal tumour: a case report. Gentile CM; Lombardi AA; Croxatto JO Br J Ophthalmol; 2008 Jan; 92(1):156-7. PubMed ID: 18156391 [No Abstract] [Full Text] [Related]
54. 'Please, desist RECIST criteria in GIST, at least in me'. Sevinc A; Turhal NS Onkologie; 2008 Oct; 31(10):556. PubMed ID: 18854657 [No Abstract] [Full Text] [Related]
55. An omental mass: any hypothesis? Caricato M; Ausania F; Valeri S; Rabitti C; Tonini G; Coppola R Colorectal Dis; 2005 Jul; 7(4):417-8. PubMed ID: 15932570 [No Abstract] [Full Text] [Related]
56. Is KIT an important therapeutic target in small cell lung cancer? Heinrich MC Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5825-8. PubMed ID: 14676102 [No Abstract] [Full Text] [Related]